Magnetic resonance (MR) imaging of the breast is currently used for ev
aluation of both parenchymal disease and silicone gel implants. MR ima
ging has the potential to address questions raised or unanswered with
traditional diagnostic imaging methods. However, lesion specificity an
d cancer sensitivity depend on multiple technical factors (ie, imaging
parameters and contrast agent delivery) and biologic factors (ie, the
menstrual status of the patient and the vascularity of the lesion), A
lthough diagnostic criteria for parenchymal disease have been reported
, overlap of malignant and benign enhancement profiles occurs, The acc
uracy of implant evaluation depends on the imaging parameters and know
ledge of the implant type and surgical history, In addition, individua
l investigative imaging methods are diverse, causing difficulty in pro
tocol development for the practicing radiologist. An awareness of the
problematic factors in breast MR imaging will improve diagnostic accur
acy and allow understanding of the limitations of the modality and ind
ividual patient examinations.